|LETTER TO THE EDITOR
|Year : 2014 | Volume
| Issue : 4 | Page : 413
Concurrent malaria infection on anticancer therapy
E Hai1, V Wiwanitkit2
1 Sanitation 1 Medical Academic Center, Bangkok, Thailand
2 Hainan Medical University, China; Faculty of Medicine, University of Nis, Serbia; Joseph Ayobabalola University, Nigeria
|Date of Web Publication||1-Feb-2016|
Dr. E Hai
Sanitation 1 Medical Academic Center, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Hai E, Wiwanitkit V. Concurrent malaria infection on anticancer therapy. Indian J Cancer 2014;51:413
The recent report on "concurrent malaria infection on anticancer therapy" is very interesting. A study by Noronha et al. concluded that "malaria is a significant problem in adult solid tumor patients, leading to multiple complications and therapy delays." In fact, malaria is a serious blood infection and it can superimpose any patients with other underlying disorder. For cancerous patients, there are few reports on concurrent malaria infection. Of interest, malaria infection can also be the trigger factor promoting development of blood cancer. Emmanuel et al. reported that "concurrent infection with multiple malaria genotypes may be related to onset of African Burkitt lymphoma." It is suggested that blood smear examination to find the possible occurrence of malaria in any febrile cancerous patients in endemic area is needed. On the other hand, long-term follow-up to detect any occurrence of hematological malignancy in the patients with a history of malarial infection is a challenging topic for further discussion.
| » References|| |
Noronha V, Goyal G, Joshi A, Gupta S, Ghosh J, Bajpai J, et al
. Presentation, complications, and impact of concurrent malaria infection on anticancer therapy. Indian J Cancer 2013;50:254-60.
Emmanuel B, Kawira E, Ogwang MD, Wabinga H, Magatti J, Nkrumah F, et al
. African Burkitt lymphoma: Age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg 2011;84:397-401.